ArticleIn vivo (Athens, Greece)

Conversion Surgery Performed Following Durvalumab Combined With Gemcitabine and Cisplatin in Cholangiocarcinoma: A Case Report.

Yoshiyuki Tagayasu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.